Register to chat with like-minded investors on our interactive forums.
The current AEGBF market cap is 3.4M. The company's latest EPS is SEK -1.9334 and P/E is -0.06.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Revenue | 0 | 218k | 15.39M | 1.71M | 92k |
| Operating Income | 0 | -10.35M | -80.16M | -366.64M | -56.16M |
| Net Income | 0 | -10.35M | -92.33M | -362.83M | -59.7M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Assets | 951k | 44.2M | 404.37M | 66.87M | 53.1M |
| Total Liabilities | 100k | 5.28M | 33.95M | 27.04M | 54.56M |
| Total Equity | 851k | 38.92M | 370.42M | 39.83M | -1.45M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Operating | N/A | -7.41M | -109.37M | -49M | -41.94M |
| Investing | N/A | -98k | 1.6M | -65k | -5.54M |
| Financing | N/A | 230k | 131.41M | 29.26M | 45.05M |
| Market Cap | 3.4M |
| Price to Earnings Ratio | -0.06 |
| Price to Sales Ratio | 36.67 |
| Price to Cash Ratio | 0.28 |
| Price to Book Ratio | -2.34 |
| Dividend Yield | - |
| Shares Outstanding | 30.88M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 0.00% |
| 52 Week High | 0.11 |
| 52 Week Low | 0.11 |
| Spread (Intraday) | 0 (0%) |
| Company Name | AegirBio AB (GM) |
| Address |
scheelev��gen 27 lund SE-223 63 |
| Website | https://www.magnasense.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
